Daewoong Co., Ltd - 21 Jan 2026 SCHEDULE 13D Report for AEON Biopharma, Inc. Common Stock, $0.0001 par value per share

Filing Manager
Daewoong Co., Ltd
Reporting Manager
Daewoong Co.,Ltd. ("DWC")
Security
AEON Biopharma, Inc. Common Stock, $0.0001 par value per share
Shares outstanding
24,024,279 shares
Disclosed Ownership
12,009,737 shares
Ownership
50%
Form type
SCHEDULE 13D
Filing time
29 Jan 2026, 21:24:10 UTC
Date of event
21 Jan 2026
Previous filing
29 Jan 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Daewoong Co.,Ltd. ("DWC") 50% 12,009,737 58,023 12,009,737 /s/ Kyu Sung Lim Kyu Sung Lim/Authorized Signatory of Daewoong Co., Ltd. 0001985493
Daewoong Pharmaceutical Co. Ltd ("DWP") 50% 12,009,737 11,951,714 0 /s/ Woo Hyun Kim Woo Hyun Kim/Authorized Signatory of Daewoong Pharmaceutical Co., Ltd.